Onderneming Fulcrum Therapeutics, Inc.
Aandelen
FULC
US3596161097
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
7,06 USD | -3,02% | +0,78% | +5,41% |
18/03 | Fulcrum Therapeutics benoemt Patrick Horn tot medisch directeur | MT |
18/03 | Fulcrum Therapeutics, Inc. Kondigt wijzigingen in de leiding aan | CI |
Vakgebied
Aantal werknemers: 76
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -55,77% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 6 | 100,0 % | 3 | 100,0 % | -55,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alex Sapir
CEO | Chief Executive Officer | 57 | 01-07-23 |
Alan Musso
DFI | Director of Finance/CFO | 61 | 07-08-23 |
Chief Tech/Sci/R&D Officer | - | 01-07-21 | |
Leslie Leinwand
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | 61 | 01-12-22 | |
Robert Gould
BRD | Director/Board Member | 69 | - |
Iain Fraser
PRN | Corporate Officer/Principal | - | 01-03-23 |
Kristina Storey
LAW | General Counsel | - | 01-11-22 |
Paul Bruno
PRN | Corporate Officer/Principal | - | 01-01-19 |
Comptroller/Controller/Auditor | - | 11-03-22 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
James Geraghty
BRD | Director/Board Member | 70 | 19-07-16 |
Director/Board Member | 70 | 01-12-16 | |
James Collins
BRD | Director/Board Member | 58 | 01-01-17 |
Robert Gould
BRD | Director/Board Member | 69 | - |
Kathryn Haviland
CHM | Chairman | 48 | 27-06-18 |
Katina Dorton
BRD | Director/Board Member | 66 | 02-01-20 |
Alex Sapir
CEO | Chief Executive Officer | 57 | 01-07-23 |
Sonja L. Banks
BRD | Director/Board Member | 55 | 08-12-21 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 62 153 638 | 61 297 958 ( 98,62 %) | 0 | 98,62 % |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+5,41% | 452 mln. | |
+0,73% | 43,84 mld. | |
+5,74% | 41,68 mld. | |
+45,26% | 41,25 mld. | |
-11,96% | 27,04 mld. | |
+6,10% | 25,53 mld. | |
-24,63% | 18,18 mld. | |
-3,28% | 12,29 mld. | |
+26,09% | 12,29 mld. | |
+6,86% | 11,15 mld. |
- Beurs
- Aandelen
- Koers FULC
- Onderneming Fulcrum Therapeutics, Inc.